Heterogeneity of tumor-initiating cell related signaling revealed by lentiviral signaling reporters in breast cancer patient-derived xenografts

被引：0
|
作者：
Landua, John [1 ]
Gong, Ping [1 ]
Lewis, Michael T. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1689
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Lentiviral signaling reporters uncover tumor-initiating cell heterogeneity in breast cancer patient-derived xenografts
    Landua, John
    Gong, Ping
    Lewis, Michael
    CANCER RESEARCH, 2020, 80 (04)
  • [2] A Chemosensitivity Study of Colorectal Cancer Using Xenografts of Patient-Derived Tumor-Initiating Cells
    Maekawa, Hisatsugu
    Miyoshi, Hiroyuki
    Yamaura, Tadayoshi
    Itatani, Yoshiro
    Kawada, Kenji
    Sakai, Yoshiharu
    Taketo, M. Mark
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (10) : 2187 - 2196
  • [3] Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
    Han, Dan
    Rodriguez-Bravo, Veronica
    Izadmehr, Sudeh
    Domingo-Domenech, Josep
    Cordon-Cardo, Carlos
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (148):
  • [4] Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
    Hanna, Colton
    Kwok, Letty
    Finlay-Schultz, Jessica
    Sartorius, Carol A.
    Cittelly, Diana M.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (117):
  • [5] Patient-derived breast tumor xenografts: a tool for identification and targeting of tumor initiating cells
    Poupon, Marie-France
    Marangoni, Elisabetta
    Assayag, Franck
    Auger, Nathalie
    de Cremoux, Patricia
    De Pinieux, Gonzague
    Vincent-Salomon, Anne
    Sastre, Xavier
    Lecomte, Nicolas
    Smadja-Joffe, Florence
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 933 - 934
  • [6] Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
    Cassidy, John W.
    Caldas, Carlos
    Bruna, Alejandra
    CANCER RESEARCH, 2015, 75 (15) : 2963 - 2968
  • [7] Inhibition of autocrine signaling as a strategy to target tumor-initiating breast cancer cells
    Scheel, Christina
    Dragoi, Diana
    Eaton, Elinor Ng
    Hsin-Jung, Li Sophia
    Reinhardt, Ferenc
    Weinberg, Robert A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)
  • [8] Signaling alterations in a collection of Cetuximab resistant and sensitive patient-derived tumor xenografts
    Krumbach, Rebekka
    Schueler, Julia
    Metz, Thomas
    Fiebig, Heinz Herbert
    Beckers, Thomas
    CANCER RESEARCH, 2009, 69
  • [9] Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
    Goetz, Matthew P.
    Kalari, Krishna R.
    Suman, Vera J.
    Moyer, Ann M.
    Yu, Jia
    Visscher, Daniel W.
    Dockter, Travis J.
    Vedell, Peter T.
    Sinnwell, Jason P.
    Tang, Xiaojia
    Thompson, Kevin J.
    McLaughlin, Sarah A.
    Moreno-Aspitia, Alvaro
    Copland, John A.
    Northfelt, Donald W.
    Gray, Richard J.
    Hunt, Katie
    Conners, Amy
    Weinshilboum, Richard
    Wang, Liewei
    Boughey, Judy C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (07):
  • [10] BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer
    Bansal, Nitu
    Bartucci, Monica
    Yusuff, Shamila
    Davis, Stephani
    Flaherty, Kathleen
    Huselid, Eric
    Patrizii, Michele
    Jones, Daniel
    Cao, Liangxian
    Sydorenko, Nadiya
    Moon, Young-Choon
    Zhong, Hua
    Medina, Daniel
    Kerrigan, John
    Stein, Mark N.
    Kim, Isaac Y.
    Davis, Thomas W.
    DiPaola, Robert S.
    Bertino, Joseph
    Sabaawy, Hatem E.
    CLINICAL CANCER RESEARCH, 2016, 22 (24) : 6176 - 6191
12345